Catherine A. Sohn

Catherine A. Sohn is a declared insider at 4 companies (board member); the most frequent names are Jazz Pharmaceuticals plc, Altimmune, Inc. and Lifecore Biomedical, Inc. \DE\. The record holds 9 filings, for trades running from 1 June 2021 to 6 January 2026.

The open-market side counts 2 purchases for €7,125 alongside 1 sale for €163k. On balance, insiders were net sellers of €156k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 5 share grants and 1 option exercise. 2026 to date brings 1 purchase and no sales.

The record was last updated on 8 January 2026 with an option exercise (€22k) in Maze Therapeutics, Inc. The last purchase on record was published on 5 January 2026, which is 286 days ago. The median gap between a trade and its publication by SEC (Form 4) is 4 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.